Identifying Novel Regulators of Mitochondrial Complex I Biogenesis
Identifying Novel Regulators of Mitochondrial Complex I Biogenesis
批准号:
9401087
负责人:
Christian Joel Garcia
金额:
$4.4万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31
关键词:
AddressBiochemistryBiogenesisBiological AssayBiological ModelsCandidate Disease GeneCardiovascular DiseasesCatalysisCattleCell Culture TechniquesCell LineCellsChronicCommunitiesComplexDegenerative DisorderDevelopmentDiseaseDrosophila genusElectron TransportEmbryoEnzymesFlavin MononucleotideGelGenerationsGeneticGoalsHeart MitochondriaHumanHydrophobicityImpairmentKnowledgeLeigh DiseaseLinkMammalian CellMass Spectrum AnalysisMembraneMembrane PotentialsMetabolic DiseasesMitochondriaMitochondrial MatrixMitochondrial ProteinsModelingMolecularMolecular ChaperonesMorphologic artifactsMuscleMutationNADHNeurospora crassaNuclearOptic AtrophyOrganismOrthologous GenePatientsPhysiologyPlayPolyacrylamide Gel ElectrophoresisProcessProteinsProteomicsReiterated GenesRoleSignal TransductionSilver StainingSkeletal MuscleStructureSystemTestingTherapeuticTimeUbiquinoneValidationWestern Blottingarmcombatenzyme activitygenetic analysishydrophilicityimprovedin vivoinnovationinsightkidney cellnovelprotein functionsarcopeniatool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Mitochondrial Complex I (CI) is composed of 44 distinct subunits, that are assembled together with eight Fe-S
clusters and a single flavin mononucleotide, to form a functioning enzyme. Ancillary proteins referred to as
assembly factors assist with the assembly process; and a dozen or so bona fide CI assembly factors (CIAFs) have
been characterized. However, about half of CI disorders cannot be traced to mutations in any of the 44 CI subunits
or known assembly factors, which suggests that additional regulators of CI biogenesis remain to be characterized.
The ideal model system for discovering new regulators of CI assembly will have to satisfy at least 4 criteria: (i) the
mechanism of CI assembly should closely mimic that of the human enzyme, (ii) it should be highly enriched with
mitochondria to enable the examination of the effects of 1000s of candidate genes on CI assembly rather easily, (iii)
the genetic tool kit in such an organism should be significantly advanced to the point where the effects of 1000s of
candidate genes on CI assembly can rapidly be tested, and finally (iv) it should be possible to analyze CI assembly
in vivo where it is subject to both developmental and environmental signals, and not prone to cell culture artifacts.
None of the current model systems for studying CI assembly (in Neurospora crassa and various mammalian cell
lines) satisfy all 4 criteria. To facilitate the discovery of novel regulators of CI assembly, we are using the
mitochondria-enriched flight muscles in Drosophila as a novel system to study CI assembly as it satisfies all four
criteria. We find that CI biogenesis in Drosophila skeletal muscles proceeds via the formation of ~315-, ~370-,
~550-, and ~815 kDa CI assembly intermediates as has been described in mammalian systems; and Drosophila CI
has a comparable number of subunits as the human enzyme. Importantly, mutations in Drosophila orthologs of
CIAFs described in humans, also impair CI assembly in Drosophila, further showing that the mechanism of CI
assembly is conserved between humans and Drosophila. Because NDUFS3 (one of the 44 CI subunits) has a
central role in CI biogenesis we hypothesize that some regulators of CI assembly may directly interact with
NDUFS3. Here, we propose to use a genetic and proteomic approach to identify novel regulators of CI assembly
that interact with NDUFS3; and test our candidate regulators in both Drosophila and human cells. The ease of
isolating copious amounts of mitochondria from flight muscles, extensive arsenal of tools for genetic analyses,
relatively short generation time, and limited gene redundancy in Drosophila are assets that should facilitate the
discovery of new regulators of CI assembly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金